These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30016351)

  • 1. Adverse pregnancy outcomes and imbalance in angiogenic growth mediators and oxidative stress biomarkers is associated with advanced maternal age births: A prospective cohort study in Ghana.
    Odame Anto E; Owiredu WKBA; Sakyi SA; Turpin CA; Ephraim RKD; Fondjo LA; Obirikorang C; Adua E; Acheampong E
    PLoS One; 2018; 13(7):e0200581. PubMed ID: 30016351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.
    Anto EO; Coall DA; Asiamah EA; Afriyie OO; Addai-Mensah O; Wiafe YA; Owiredu W; Obirikorang C; Annani-Akollor ME; Titiloye NA; Adua E; Acheampong E; Adu EA; Opoku S; Anto AO; Tawiah A; Wang Y; Wang W
    PLoS One; 2022; 17(3):e0265717. PubMed ID: 35312727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal health pregnant women are associated with increased oxidative stress and unbalanced pro- and antiangiogenic growth mediators: a cross-sectional study in a Ghanaian population.
    Anto EO; Roberts P; Coall DA; Adua E; Turpin CA; Tawiah A; Wang Y; Wang W
    Free Radic Res; 2020 Jan; 54(1):27-42. PubMed ID: 31814473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
    Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
    Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective cohort study providing insights for markers of adverse pregnancy outcome in older mothers.
    Lean SC; Jones RL; Roberts SA; Heazell AEP
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):706. PubMed ID: 34670515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
    Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
    Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between micronutrients, oxidative stress biomarkers and angiogenic growth mediators in early and late-onset preeclamptic Ghanaian women.
    Anto EO; Ofori Boadu WI; Addai-Mensah O; Wiafe YA; Owiredu WK; Obirikorang C; Annani-Akollor ME; Adua E; Appiah M; Opoku S; Acheampong E; Asamoah EA; Owiredu EW; Odame Anto A; Tawiah A; Ankobea F; Afrifa Yamoah E; Coall DA
    SAGE Open Med; 2023; 11():20503121231175759. PubMed ID: 37324117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction.
    Shinohara S; Uchida Y; Kasai M; Sunami R
    Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Serum Angiogenic Growth Factors in Intrauterine Growth Restriction versus Normal Pregnancies.
    Komwilaisak R; Tangkiratichai P
    J Med Assoc Thai; 2017 Feb; 100(2):119-24. PubMed ID: 29916230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive care patients with preeclampsia - Clinical risk factors and biomarkers for oxidative stress and angiogenic imbalance as discriminators for severe disease.
    Edvinsson C; Hansson E; Nielsen N; Erlandsson L; Hansson SR
    Pregnancy Hypertens; 2022 Dec; 30():88-94. PubMed ID: 36108544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic growth factors, oxidative stress and haematobiochemical measures as predictors of preeclampsia with and without foetal growth restriction: A case-control study in a Ghanaian population.
    Anto EO; Boadu WIO; Hughes C; Korsah EE; Frimpong J; Ansah E; Tawiah A; Tamakloe VCKT; Acheampong E; Asamoah EA; Opoku S; Aboagye E; Albright EM; Adua E; Afrifa-Yamoah E; Anto AO; Annani-Akollor ME; Wiafe YA; Obirikorang C
    Placenta; 2024 Jan; 145():130-138. PubMed ID: 38134545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early gestational profiling of oxidative stress and angiogenic growth mediators as predictive, preventive and personalised (3P) medical approach to identify suboptimal health pregnant mothers likely to develop preeclampsia.
    Anto EO; Coall DA; Addai-Mensah O; Wiafe YA; Owiredu WKBA; Obirikorang C; Annani-Akollor ME; Adua E; Tawiah A; Acheampong E; Asamoah EA; Wang X; Opoku S; Boakye DK; Hou H; Wang Y; Wang W;
    EPMA J; 2021 Dec; 12(4):517-534. PubMed ID: 34956424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.
    Verlohren S; Galindo A; Schlembach D; Zeisler H; Herraiz I; Moertl MG; Pape J; Dudenhausen JW; Denk B; Stepan H
    Am J Obstet Gynecol; 2010 Feb; 202(2):161.e1-161.e11. PubMed ID: 19850276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-delivery angiogenic factors and their association with peripartum perceived stress and pain in pre-eclampsia with severe features and normotensive pregnancies.
    Ngene NC; Moodley J
    Int J Gynaecol Obstet; 2022 Aug; 158(2):398-405. PubMed ID: 34622454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes.
    Coolman M; Timmermans S; de Groot CJ; Russcher H; Lindemans J; Hofman A; Geurts-Moespot AJ; Sweep FC; Jaddoe VV; Steegers EA
    Obstet Gynecol; 2012 Jun; 119(6):1190-200. PubMed ID: 22617584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis-related biomarkers (sFlt-1/PlGF) in placental mesenchymal dysplasia.
    Herraiz I; Simón E; Toldos Ó; Rodríguez Y; Gómez-Arriaga PI; Galindo A
    J Matern Fetal Neonatal Med; 2017 Apr; 30(8):958-961. PubMed ID: 27240524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.